Moderna CEO Hearing Highlights Dissatisfaction With Patient Assistance Programs

 
• By Sarah Karlin-Smith

There was bipartisan agreement that Moderna needs to ensure that its patient assistance program will be easily accessible for under- and uninsured patients once the US switches to a commercial market for COVID vaccines – a sign of broader frustration with industry copay support initiatives.

Bernie vs Bancel
Sen. Bernie Sanders and Moderna CEO Stéphane Bancel did not see eye to eye at the 22 March hearing. • Source: Nielsen Hobbs; the Pink Sheet | Screenshots and Shutterstock images

More from Pricing Debate

More from Market Access